Business

Fermenta 9MFY26 Consolidated Revenues up 25% YoY; Net profit up 20% YoY

Fermenta Biotech Limited (BSE: 506414) (Bloomberg: FERMENTA.IN) (Reuters: FERM.BO), India's leading manufacturer of premium-grade APIs, intermediates, and mixes of vitamins and minerals for the global markets, today announced that its consolidated revenue (other than from real estate) for the nine months ended 31 December 2025 was INR 413.6 crore, up 41% from the same year-ago period; EBITDA for the nine months ended 31 December 2025 was INR 95.1 crore, up 86% from the same year-ago period on th

articleFermenta Biotech LtdFebruary 10, 20267/company/fermenta-biotech-ltd/news/fermenta-9mfy26-consolidated-revenues-up-25percent-yoy-net-profit-up-20percent-yoy
Fermenta 9MFY26 Consolidated Revenues up 25% YoY; Net profit up 20% YoY

About this update from Fermenta Biotech Ltd

[{"type":"text","content":"On the back of strong growth in Vitamin D3 - Human Nutrition:","length":61,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Consolidated Revenue for 9MFY26 INR 421.2 crore, up by INR 83.6 crore YoY","length":73,"tagName":"p"}]},{"val":[{"type":"text","content":"Consolidated EBITDA for 9MFY26 INR 97.2 crore, up 20% YoY","length":57,"tagName":"p"}]},{"val":[{"type":"text","content":"Q3FY26 Consolidated Revenues INR 140.5 crore, down 11% YoY; up 4% QoQ","length":69,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":199,"olType":false},{"type":"text","content":"MUMBAI, India, Feb. 10, 2026 /PRNewswire/ -- Fermenta Biotech Limited (BSE: 506414) (Bloomberg: FERMENTA.IN) (Reuters: FERM.BO), India's leading manufacturer of premium-grade APIs, intermediates, and mixes of vitamins and minerals for the global markets, today announced that its consolidated revenue (other than from real estate) for the nine months ended 31 December 2025 was INR 413.6 crore, up 41% from the same year-ago period; EBITDA for the nine months ended 31 December 2025 was INR 95.1 crore, up 86% from the same year-ago period on the back of strong growth in Vitamin D3 - Human Nutrition.","length":615,"tagName":"p"},{"type":"image","alt":"Fermenta BiotechLimited Logo","displaySize":"","headline":null,"caption":"Fermenta BiotechLimited Logo","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":391,"url":"https://media.zenfs.com/en/prnewswire.com/bafb7c230f8fa999083248e13f3b4cf0"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/iQCgUU_tH2ryAQJyh3_vbQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTY4OTtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/bafb7c230f8fa999083248e13f3b4cf0","width":400,"height":391}}},{"type":"text","content":"Key financials (consolidated) without real estate","length":49,"tagName":"p"},{"type":"table","headerItems":[],"items":[{"val":[{"colspan":"1","rowspan":"1","style":"PADDING-RIGHT:0.17em;PADDING-LEFT:0.17em;VERTICAL-ALIGN:TOP;","val":[{"type":"text","content":"","length":0,"tagName":"p","attribs":{}}]},{"colspan":"1","rowspan":"1","style":"PADDING-RIGHT:0.17em;PADDING-LEFT:0.17em;VERTICAL-ALIGN:TOP;TEXT-ALIGN:CENTER;","val":[{"type":"text","content":"Q3FY26","length":6,"tagName":"p","attribs":{}}]},{"colspan":"1","rowspan":"1","style":"PADDING-RIGHT:0.17em;PADDING-...

More updates from Fermenta Biotech Ltd

Fermenta Biotech Limitedreal estateHuman NutritionConsolidated RevenueVitamin D3FermentaYoY